High Court Won't Hear 'Reverse Payment' Challenge

Law360, New York (June 22, 2009, 12:00 AM EDT) -- The U.S. Supreme Court on Monday declined to take up a high-profile antitrust challenge to reverse payments, denying a certiorari petition after Bayer AG and generic-drug makers struck a deal that kept a generic off the market.

The nation's top court was petitioned after the U.S. Court of Appeals for the Federal Circuit upheld the dismissal of an antitrust challenge to millions of dollars in payments made by the German pharmaceutical giant to Barr Laboratories Inc., among others, to settle patent litigation related to the Cipro...
To view the full article, register now.